US Patent No. 9,222,936

Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization
Dec 31, 2015

Solulink and the University of Chicago have been awarded US Patent No. 9,222,936, "Methods and/or use of oligonucleotide conjugates for suppressing background due to cross-hybridization."

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.